Daré Bioscience Highlights Revenue Opportunity as CEO Discusses Upcoming Launch of Flora Sync LF5™ in Virtual Investor “What This Means” Segment
First consumer health product positions Daré for revenue generation while expanding its women's health leadership platform Access the segment here...
Hemostemix to Highlight Commercial Phase I Longevity Treatment at Small Cap Growth Investor Conference